# 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives

**Authors:** Filipe Areias, Carla Correia, Ashly Rocha, Sofia Teixeira, Marián Castro, Jose Brea, Huabin Hu, Jens Carlsson, Maria I. Loza, M. Fernanda Proença, M. Alice Carvalho

PMC · DOI: 10.3390/molecules29112543 · Molecules · 2024-05-28

## TL;DR

This study explores new 2-aryladenine compounds that act as strong blockers of adenosine receptors, which could lead to new drugs or research tools.

## Contribution

The paper introduces new 2-aryladenine derivatives with potent and selective adenosine receptor antagonism.

## Key findings

- Eleven compounds showed potent antagonism at various adenosine receptor subtypes.
- Three compounds had high affinity but no selectivity for specific receptors.
- Structure-activity relationships revealed potency and selectivity differences between 9-methyl and 9H-purine derivatives.

## Abstract

A set of 2-aryl-9-H or methyl-6-morpholinopurine derivatives were synthesized and assayed through radioligand binding tests at human A1, A2A, A2B, and A3 adenosine receptor subtypes. Eleven purines showed potent antagonism at A1, A3, dual A1/A2A, A1/A2B, or A1/A3 adenosine receptors. Additionally, three compounds showed high affinity without selectivity for any specific adenosine receptor. The structure-activity relationships were made for this group of new compounds. The 9-methylpurine derivatives were generally less potent but more selective, and the 9H-purine derivatives were more potent but less selective. These compounds can be an important source of new biochemical tools and/or pharmacological drugs.

## Linked entities

- **Chemicals:** 9-methylpurine (PubChem CID 140687), 9H-purine (PubChem CID 1044)

## Full-text entities

- **Genes:** IGKV2D-29 (immunoglobulin kappa variable 2D-29) [NCBI Gene 28882] {aka A2a, A2c, IGKV2D29}
- **Chemicals:** purines (MESH:D011687), 2-Aryladenine Derivatives (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A2A, A3 adenosine

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11173536/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11173536/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC11173536/full.md

---
Source: https://tomesphere.com/paper/PMC11173536